Clinical Microbiology Market - Global Forecast To 2030
商品番号 : SMB-58341
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年9月 |
| ページ数 | 411 |
| 図表数 | 529 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
この調査レポートでは、臨床微生物学市場を製品別（機器、試薬、培地・血清）、疾患領域別（呼吸器疾患、血流感染症、胃腸疾患、性感染症、尿路感染症、歯周病、その他の疾患）、エンドユーザー別（病院・診断センター、契約検査機関、学術研究機関）、地域別（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東・アフリカ）に分類しています。
本レポートは、臨床微生物学市場全体および各サブセグメントの収益数値に関する近似値に関する情報を提供し、市場リーダー／新規参入企業にとって役立ちます。また、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。さらに、本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、機会、課題に関する情報を提供するのにも役立ちます。
臨床微生物学市場は2030年までに73億4000万米ドルに達し、予測期間中に年平均成長率（CAGR）6.6%で成長すると予測されています。臨床微生物学市場は、迅速な分子検査やラボの自動化といった診断技術の進歩により、感染性病原体の迅速かつ正確な検出が可能になり、力強い成長を遂げています。さらに、人口増加、都市化、海外旅行の増加を背景に、感染症の世界的負担は増加しており、高度な微生物学検査ソリューションに対する需要がさらに高まっています。
The clinical microbiology market is projected to reach USD 7.34 billion by 2030, growing at a CAGR of 6.6% during the forecast period. The clinical microbiology market is witnessing strong growth, driven by advancements in diagnostic technologies such as rapid molecular testing and laboratory automation, which enable faster & accurate detection of infectious agents. In addition, the rising global burden of infectious diseases, fueled by population growth, urbanization, and increased international travel, further accelerates the demand for advanced microbiology testing solutions.
By product, the instruments segment accounted for the largest market share in 2024.
The clinical microbiology market is segmented into instruments, reagents, and media & sera. The instruments segment accounted for the largest share of the market. This dominance is driven by several factors, including the widespread adoption of conventional laboratory instruments by researchers & academic institutions, alongside increasing industry-academia collaborations in genomic research. Additionally, molecular techniques and proteomics advancements, such as integrating microfluidics with PCR and applying nanotechnology to qPCR, are fuelling the growth.
By end user, the hospitals & diagnostic centers segment accounted for the largest share of the market in 2024.
The market is segmented by end user into hospitals & diagnostic centers, contract testing laboratories, and academic & research institutes. In 2024, the hospitals & diagnostic laboratories segment accounted for the largest market share owing to the rising establishment of hospitals, the increasing outsourcing of R&D activities to diagnostic laboratories, the increasing burden of chronic diseases, and the ability of hospitals to invest in advanced healthcare infrastructure.
Asia Pacific is projected to grow at the highest CAGR during the forecast period.
The global clinical microbiology market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest growth rate during the forecast period. Emerging economies in this region are seeing consistent GDP growth and a notable rise in disposable income, contributing to increased healthcare spending across a broader population base. Additional growth drivers include the rising incidence and prevalence of infectious diseases, the modernization of healthcare infrastructure, and the growing adoption of advanced diagnostic technologies, particularly in rural areas. These factors are anticipated to create substantial growth opportunities for clinical microbiology companies in the Asia Pacific.
The break-up of the profile of primary participants in the clinical microbiology market:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C-level – 27%, D-level – 18%, and Others – 55%
- By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and the Middle East & Africa- 4%
The key players in this market are bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Agilent Technologies, Inc. (US), Bruker Corporation (US), Hologic, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), Siemens Healthineers AG (Germany), Shimadzu Corporation (Japan), and Neogen Corporation (US), among others.
Research Coverage:
This research report categorizes the clinical microbiology market by product (instruments, reagents, and media & sera), by disease area (respiratory diseases, bloodstream infections, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other diseases), by end user (hospitals & diagnostic centers, contract testing laboratories, and academic & research institutes), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
Reasons To Buy This Report:
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall clinical microbiology market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (technological advancements in clinical diagnosis and novel molecular diagnostic-based instruments, rising incidence of infectious diseases and epidemics, increasing R&D programs and public-private investments), opportunities (improved healthcare infrastructure in emerging countries), restraints (limited reimbursement policies for clinical microbiology testing procedures), and challenges (operational barriers to diagnostic microbiology tests in emerging countries) influencing the growth of the clinical microbiology market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the clinical microbiology market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the clinical microbiology market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the clinical microbiology market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), and F. Hoffmann-La Roche Ltd. (Switzerland), among others, in the clinical microbiology market.
Table of Contents
1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 MARKET SCOPE 36
1.3.1 MARKETS & REGIONS COVERED 36
1.3.2 INCLUSIONS & EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.3.4 CURRENCY CONSIDERED 38
1.4 KEY STAKEHOLDERS 38
1.5 SUMMARY OF CHANGES 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.2 RESEARCH APPROACH 40
2.2.1 SECONDARY DATA 41
2.2.1.1 Key secondary sources 41
2.2.1.2 Key data from secondary sources 42
2.2.2 PRIMARY DATA 43
2.2.2.1 Primary sources 43
2.2.2.2 Key data from primary sources 44
2.2.2.3 Key industry insights 45
2.2.2.4 Breakdown of primary interviews 45
2.3 MARKET SIZE ESTIMATION 46
2.3.1 BOTTOM-UP APPROACH 46
2.3.1.1 Approach 1: Company revenue estimation approach 47
2.3.1.2 Approach 2: Presentations of companies and primary interviews 47
2.3.1.3 Growth forecast 47
2.3.1.4 CAGR projections 48
2.3.2 TOP-DOWN APPROACH 48
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 50
2.5 MARKET SHARE ASSESSMENT 51
2.6 RESEARCH ASSUMPTIONS 51
2.7 RESEARCH LIMITATIONS 51
2.8 RISK ASSESSMENT 52
3 EXECUTIVE SUMMARY 53
4 PREMIUM INSIGHTS 57
4.1 CLINICAL MICROBIOLOGY MARKET OVERVIEW 57
4.2 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 58
4.3 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2025 VS. 2030 (USD MILLION) 58
4.4 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 59
4.5 CLINICAL MICROBIOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
5.2.1 DRIVERS 61
5.2.1.1 Technological advancements and development of novel molecular diagnostic-based instruments 61
5.2.1.2 Rising incidence of infectious diseases and epidemics 62
5.2.1.3 Increasing focus on R&D programs and public-private investments 63
5.2.2 RESTRAINTS 64
5.2.2.1 Limited reimbursement policies for clinical microbiology testing procedures 64
5.2.3 OPPORTUNITIES 64
5.2.3.1 Improved healthcare infrastructure in emerging economies 64
5.2.4 CHALLENGES 65
5.2.4.1 Operational barriers for diagnostic microbiology tests 65
5.3 PRICING ANALYSIS 65
5.3.1 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS 65
5.3.2 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY TEST KITS,
BY KEY PLAYER, 2023−2025 66
5.3.3 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS, BY REGION, 2023−2025 67
5.4 PATENT ANALYSIS 68
5.4.1 LIST OF MAJOR PATENTS 69
5.5 VALUE CHAIN ANALYSIS 70
5.6 SUPPLY CHAIN ANALYSIS 71
5.7 TRADE ANALYSIS 72
5.7.1 TRADE ANALYSIS FOR OPTICAL MICROSCOPES 72
5.7.2 IMPORT DATA (HS CODE 9011) 73
5.7.3 EXPORT DATA (HS CODE 9011) 73
5.8 ECOSYSTEM ANALYSIS 74
5.8.1 CLINICAL MICROBIOLOGY MARKET: ROLE IN ECOSYSTEM 74
5.9 PORTER’S FIVE FORCES ANALYSIS 75
5.9.1 THREAT OF NEW ENTRANTS 76
5.9.2 THREAT OF SUBSTITUTES 76
5.9.3 BARGAINING POWER OF BUYERS 76
5.9.4 BARGAINING POWER OF SUPPLIERS 77
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 77
5.10 REGULATORY LANDSCAPE 77
5.10.1 REGULATORY FRAMEWORK 77
5.10.1.1 North America 77
5.10.1.1.1 US 77
5.10.1.1.2 Canada 77
5.10.1.2 Europe 78
5.10.1.2.1 Germany 78
5.10.1.2.2 UK 79
5.10.1.2.3 France 79
5.10.1.2.4 Italy 79
5.10.1.3 Asia Pacific 80
5.10.1.3.1 China 80
5.10.1.3.2 Japan 80
5.10.1.3.3 India 80
5.10.1.4 Latin America 81
5.10.1.4.1 Brazil 81
5.10.1.4.2 Mexico 81
5.10.1.5 Middle East 81
5.10.1.5.1 Africa 82
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
5.11 TECHNOLOGY ANALYSIS 84
5.11.1 KEY TECHNOLOGIES 84
5.11.1.1 MALDI-TOF mass spectrometry 84
5.11.2 COMPLEMENTARY TECHNOLOGIES 84
5.11.2.1 Optical immunosensors 85
5.11.2.2 Electrochemical immunosensors 85
5.11.3 ADJACENT TECHNOLOGIES 85
5.11.3.1 Automated multiplex PCR systems 85
5.12 KEY CONFERENCES & EVENTS, 2025–2026 85
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 87
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 88
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
5.14.2 BUYING CRITERIA 89
5.15 INVESTMENT & FUNDING SCENARIO 89
5.16 CASE STUDY ANALYSIS 90
5.16.1 CASE STUDY 1: IMPACT OF MALDI-TOF MS AND RAPID SUSCEPTIBILITY TESTING ON SEPSIS MANAGEMENT 90
5.16.2 CASE STUDY 2: IMPACT OF MULTIPLEX PCR PANELS IN MANAGING ACUTE GASTROENTERITIS IN ED 91
5.17 IMPACT OF AI/GENERATIVE AI IN CLINICAL MICROBIOLOGY MARKET 91
5.17.1 INTRODUCTION 91
5.17.2 MARKET POTENTIAL OF AI 92
5.17.3 AI-USE CASES 92
5.17.4 IMPLEMENTATION OF AI, BY KEY COMPANY & CASE 93
5.17.5 FUTURE OF AI IN CLINICAL MICROBIOLOGY MARKET 94
5.18 TRUMP TARIFF IMPACT ON CLINICAL MICROBIOLOGY MARKET 94
5.18.1 INTRODUCTION 94
5.18.2 KEY TARIFF RATES 95
5.18.3 PRICE IMPACT ANALYSIS 95
5.18.4 KEY IMPACT ON COUNTRY/REGION 96
5.18.4.1 North America 96
5.18.4.2 Europe 96
5.18.4.3 Asia Pacific 96
5.18.5 IMPACT ON END-USE INDUSTRIES 96
5.18.5.1 Hospitals & diagnostic centers 96
5.18.5.2 Contract testing laboratories 97
5.18.5.3 Academic & research institutes 97
6 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT 98
6.1 INTRODUCTION 99
6.2 INSTRUMENTS 99
6.2.1 LABORATORY INSTRUMENTS 103
6.2.1.1 Incubators 106
6.2.1.1.1 Rising demand for cell culture applications to drive market 106
6.2.1.2 Gram stainers 109
6.2.1.2.1 Rapid, accurate screening of bacterial pathogens to
fuel uptake 109
6.2.1.3 Bacterial colony counters 112
6.2.1.3.1 Increased focus on accurate bacterial quantification to drive market 112
6.2.1.4 Autoclave sterilizers 115
6.2.1.4.1 Increasing focus on infection control in healthcare facilities to support market growth 115
6.2.1.5 Microbial air samplers 118
6.2.1.5.1 Need for enhanced air quality monitoring in cleanrooms to accelerate segment growth 118
6.2.1.6 Anaerobic culture systems 121
6.2.1.6.1 Increased research on anaerobic microorganisms to boost segment growth 121
6.2.1.7 Petri dish fillers 124
6.2.1.7.1 Need for minimal bench space and effective control with graphical user interfaces to aid segment growth 124
6.2.1.8 Blood culture systems 127
6.2.1.8.1 Technological advancements in diagnostic testing to drive market 127
6.2.1.9 Microbial culture systems 130
6.2.1.9.1 Increase in biopharmaceutical research to augment segment growth 130
6.2.1.10 Other laboratory instruments 133
6.2.2 MICROBIOLOGY ANALYZERS 136
6.2.2.1 Molecular diagnostic instruments 140
6.2.2.1.1 Advancements in multiplexing techniques and high adoption of genomics-based analysis to aid market growth 140
6.2.2.2 Microscopes 143
6.2.2.2.1 Rising demand for high-resolution imaging to propel market 143
6.2.2.3 Mass spectrometers 146
6.2.2.3.1 Increased applications in proteomics & metabolomics to boost market 146
6.3 REAGENTS 148
6.3.1 PATHOGEN-SPECIFIC KITS 152
6.3.1.1 Increasing private-public initiatives for research to support market growth 152
6.3.2 GENERAL REAGENTS 154
6.3.2.1 Rising demand for diagnostic tests for pathogen detection to propel segment growth 154
6.4 MEDIA & SERA 157
6.4.1 RISING DEMAND FOR STANDARDIZED CULTURE MEDIA FOR MICROBIOLOGICAL TESTING TO PROPEL MARKET 157
7 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA 161
7.1 INTRODUCTION 162
7.2 RESPIRATORY DISEASES 162
7.2.1 EXPANSION OF RESPIRATORY DISEASE SURVEILLANCE PROGRAMS
TO DRIVE MARKET 162
7.3 BLOODSTREAM INFECTIONS 166
7.3.1 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
TO DRIVE MARKET 166
7.4 GASTROINTESTINAL DISEASES 169
7.4.1 HIGH RISK OF FOOD- AND WATER-BORNE INFECTIONS TO AID MARKET 169
7.5 SEXUALLY TRANSMITTED DISEASES 172
7.5.1 INCREASING EMPHASIS ON EARLY & EFFECTIVE DISEASE DIAGNOSIS
TO BOOST DEMAND 172
7.6 URINARY TRACT INFECTIONS 176
7.6.1 FOCUS ON PREVENTIVE CARE TO SUPPORT MARKET GROWTH 176
7.7 PERIODONTAL DISEASES 179
7.7.1 INCREASING R&D INITIATIVES TO STUDY MICROBE-INDUCED DISEASES
TO FUEL MARKET 179
7.8 OTHER DISEASES 182
8 CLINICAL MICROBIOLOGY MARKET, BY END USER 186
8.1 INTRODUCTION 187
8.2 HOSPITALS & DIAGNOSTIC CENTERS 187
8.2.1 INCREASING PATIENT VOLUME AND RISING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET 187
8.3 CONTRACT TESTING LABORATORIES 191
8.3.1 LOW-COST OUTSOURCING OF TESTING ACTIVITIES TO LABORATORIES TO PROPEL MARKET 191
8.4 ACADEMIC & RESEARCH INSTITUTES 194
8.4.1 EXPANSION OF RESEARCH INITIATIVES AND FAVORABLE FUNDING INVESTMENTS TO BOOST MARKET 194
9 CLINICAL MICROBIOLOGY MARKET, BY REGION 197
9.1 INTRODUCTION 198
9.2 NORTH AMERICA 199
9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 204
9.2.2 US 205
9.2.2.1 Increasing prevalence of infectious diseases to drive market 205
9.2.3 CANADA 209
9.2.3.1 Supportive government initiatives and increased research funding to boost market 209
9.3 EUROPE 213
9.3.1 EUROPE: MACROECONOMIC OUTLOOK 217
9.3.2 GERMANY 218
9.3.2.1 Favorable government policies to propel market 218
9.3.3 FRANCE 222
9.3.3.1 Favorable healthcare reforms and investments in diagnostic infrastructure to drive market 222
9.3.4 UK 226
9.3.4.1 Rising acceptance of genome-based diagnostic techniques to fuel market 226
9.3.5 ITALY 230
9.3.5.1 Improved healthcare services and better disease surveillance to support market growth 230
9.3.6 SPAIN 234
9.3.6.1 Growing focus on public healthcare initiatives to augment market growth 234
9.3.7 REST OF EUROPE 238
9.4 ASIA PACIFIC 242
9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 246
9.4.2 CHINA 247
9.4.2.1 Increasing government focus on disease prevention to drive market 247
9.4.3 JAPAN 251
9.4.3.1 Technological advancements in diagnostic kits to fuel uptake 251
9.4.4 INDIA 255
9.4.4.1 High target patient population to boost demand 255
9.4.5 SOUTH KOREA 259
9.4.5.1 Favorable government initiatives for medical tourism to support market growth 259
9.4.6 AUSTRALIA 263
9.4.6.1 Favorable healthcare automation techniques to support market growth 263
9.4.7 REST OF ASIA PACIFIC 267
9.5 LATIN AMERICA 271
9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 275
9.5.2 BRAZIL 276
9.5.2.1 Universal healthcare access to drive market 276
9.5.3 MEXICO 279
9.5.3.1 Increasing prevalence of HIV to drive market 279
9.5.4 REST OF LATIN AMERICA 283
9.6 MIDDLE EAST & AFRICA 287
9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 292
9.6.2 KINGDOM OF SAUDI ARABIA (KSA) 292
9.6.2.1 Increasing focus on healthcare automation to drive market 292
9.6.3 UNITED ARAB EMIRATES (UAE) 296
9.6.3.1 Improvements in healthcare infrastructure to support market growth 296
9.6.4 REST OF MIDDLE EAST & AFRICA 300
10 COMPETITIVE LANDSCAPE 304
10.1 INTRODUCTION 304
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 304
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET 304
10.3 REVENUE SHARE ANALYSIS 307
10.4 MARKET SHARE ANALYSIS, 2024 308
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 310
10.5.1 STARS 310
10.5.2 EMERGING LEADERS 310
10.5.3 PERVASIVE PLAYERS 310
10.5.4 PARTICIPANTS 310
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 312
10.5.5.1 Company footprint 312
10.5.5.2 Region footprint 312
10.5.5.3 Product footprint 313
10.5.5.4 Instruments footprint 314
10.5.5.5 Disease area footprint 314
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 315
10.6.1 PROGRESSIVE COMPANIES 315
10.6.2 RESPONSIVE COMPANIES 315
10.6.3 DYNAMIC COMPANIES 315
10.6.4 STARTING BLOCKS 315
10.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 317
10.6.5.1 Detailed list of key startups/SMEs 317
10.6.5.2 Competitive benchmarking of startups/SMEs (1/2) 317
10.6.5.3 Competitive benchmarking of startups/SMEs (2/2) 318
10.7 COMPANY VALUATION & FINANCIAL METRICS 318
10.7.1 FINANCIAL METRICS 318
10.7.2 COMPANY VALUATION 319
10.8 BRAND/PRODUCT COMPARISON 319
10.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS 319
10.9 COMPETITIVE SCENARIO 320
10.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 320
10.9.2 DEALS 321
10.9.3 EXPANSIONS 322
11 COMPANY PROFILES 323
11.1 KEY PLAYERS 323
11.1.1 BIOMÉRIEUX 323
11.1.1.1 Business overview 323
11.1.1.2 Products/Services offered 325
11.1.1.3 Recent developments 327
11.1.1.3.1 Product/Service launches & approvals 327
11.1.1.3.2 Deals 328
11.1.1.4 MnM view 330
11.1.1.4.1 Key strengths 330
11.1.1.4.2 Strategic choices 330
11.1.1.4.3 Weaknesses & competitive threats 330
11.1.2 DANAHER CORPORATION 331
11.1.2.1 Business overview 331
11.1.2.2 Products/Services offered 333
11.1.2.3 Recent developments 334
11.1.2.3.1 Product/Service launches & approvals 334
11.1.2.3.2 Deals 335
11.1.2.3.3 Expansions 335
11.1.2.4 MnM view 336
11.1.2.4.1 Key strengths 336
11.1.2.4.2 Strategic choices 336
11.1.2.4.3 Weaknesses & competitive threats 336
11.1.3 BECTON, DICKINSON AND COMPANY (BD) 337
11.1.3.1 Business overview 337
11.1.3.2 Products/Services offered 338
11.1.3.3 Recent developments 340
11.1.3.3.1 Product/Service launches & approvals 340
11.1.3.3.2 Deals 341
11.1.3.3.3 Expansions 342
11.1.3.4 MnM view 342
11.1.3.4.1 Key strengths 342
11.1.3.4.2 Strategic choices 342
11.1.3.4.3 Weaknesses & competitive threats 342
11.1.4 THERMO FISHER SCIENTIFIC INC. 343
11.1.4.1 Business overview 343
11.1.4.2 Products/Services offered 344
11.1.4.3 Recent developments 347
11.1.4.3.1 Product/Service launches & approvals 347
11.1.4.3.2 Deals 348
11.1.4.4 MnM view 348
11.1.4.4.1 Key strengths 348
11.1.4.4.2 Strategic choices 348
11.1.4.4.3 Weaknesses & competitive threats 348
11.1.5 F. HOFFMANN-LA ROCHE LTD. 349
11.1.5.1 Business overview 349
11.1.5.2 Products/Services offered 350
11.1.5.3 Recent developments 351
11.1.5.3.1 Product/Service launches & approvals 351
11.1.5.3.2 Deals 352
11.1.5.3.3 Expansions 352
11.1.5.4 MnM view 353
11.1.5.4.1 Key strengths 353
11.1.5.4.2 Strategic choices 353
11.1.5.4.3 Weaknesses & competitive threats 353
11.1.6 ABBOTT LABORATORIES 354
11.1.6.1 Business overview 354
11.1.6.2 Products/Services offered 356
11.1.6.3 Recent developments 361
11.1.6.3.1 Deals 361
11.1.7 AGILENT TECHNOLOGIES, INC. 362
11.1.7.1 Business overview 362
11.1.7.2 Products/Services offered 363
11.1.7.3 Recent developments 364
11.1.7.3.1 Expansions 364
11.1.8 BRUKER CORPORATION 365
11.1.8.1 Business overview 365
11.1.8.2 Products/Services offered 366
11.1.8.3 Recent developments 367
11.1.8.3.1 Product/Service launches & approvals 367
11.1.8.3.2 Deals 367
11.1.9 HOLOGIC, INC. 368
11.1.9.1 Business overview 368
11.1.9.2 Products/Services offered 369
11.1.9.3 Recent developments 370
11.1.9.3.1 Product/Service launches & approvals 370
11.1.9.3.2 Deals 371
11.1.10 MERCK KGAA 372
11.1.10.1 Business overview 372
11.1.10.2 Products/Services offered 373
11.1.10.3 Recent developments 374
11.1.10.3.1 Deals 374
11.1.10.3.2 Expansions 374
11.1.11 BIO-RAD LABORATORIES, INC. 376
11.1.11.1 Business overview 376
11.1.11.2 Products/Services offered 377
11.1.11.3 Recent developments 379
11.1.11.3.1 Deals 379
11.1.12 QIAGEN 380
11.1.12.1 Business overview 380
11.1.12.2 Products/Services offered 381
11.1.12.3 Recent developments 382
11.1.12.3.1 Product/Service launches 382
11.1.12.3.2 Deals 383
11.1.12.3.3 Expansions 383
11.1.13 SIEMENS HEALTHINEERS AG 384
11.1.13.1 Business overview 384
11.1.13.2 Products/Services offered 385
11.1.13.3 Recent developments 386
11.1.13.3.1 Product/Service launches 386
11.1.13.3.2 Deals 386
11.1.13.3.3 Expansions 387
11.2 OTHER PLAYERS 388
11.2.1 SHIMADZU CORPORATION 388
11.2.2 NEOGEN CORPORATION 389
11.2.3 SEEGENE INC. 390
11.2.4 RAPID MICRO BIOSYSTEMS, INC. 391
11.2.5 HARDY DIAGNOSTICS 392
11.2.6 EMSL ANALYTICAL, INC. 395
11.2.7 LIOFILCHEM S.R.L. 396
11.2.8 TCS BIOSCIENCES LTD. 397
11.2.9 MEMMERT GMBH + CO.KG 398
11.2.10 VACUTEST KIMA S.R.L 399
11.2.11 CREATIVE DIAGNOSTICS 400
11.2.12 DCN DX 401
12 APPENDIX 402
12.1 DISCUSSION GUIDE 402
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 407
12.3 CUSTOMIZATION OPTIONS 409
12.4 RELATED REPORTS 409
12.5 AUTHOR DETAILS 410
LIST OF TABLES
TABLE 1 CLINICAL MICROBIOLOGY MARKET: INCLUSIONS & EXCLUSIONS 37
TABLE 2 CLINICAL MICROBIOLOGY MARKET: KEY DATA FROM PRIMARY SOURCES 44
TABLE 3 CLINICAL MICROBIOLOGY MARKET: RISK ASSESSMENT ANALYSIS 52
TABLE 4 AVERAGE SELLING PRICING TREND OF CLINICAL MICROBIOLOGY
PRODUCTS, 2023–2025 66
TABLE 5 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY
TEST KITS & ASSAYS, BY KEY PLAYER, 2023–2025 66
TABLE 6 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS,
BY REGION, 2023–2025 67
TABLE 7 LIST OF MAJOR PATENTS, 2023–2025 69
TABLE 8 IMPORT DATA FOR OPTICAL MICROSCOPES (HS CODE 9011), BY COUNTRY,
2020–2024 (USD MILLION) 73
TABLE 9 EXPORT DATA FOR OPTICAL MICROSCOPES (HS CODE 3822), BY COUNTRY,
2020–2024 (USD MILLION) 73
TABLE 10 CLINICAL MICROBIOLOGY MARKET: ROLE IN ECOSYSTEM 74
TABLE 12 CLASSIFICATION OF IVD DEVICES IN EUROPE 78
TABLE 13 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 80
TABLE 16 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 19 CLINICAL MICROBIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 86
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CLINICAL MICROBIOLOGY PRODUCTS (%) 88
TABLE 21 KEY BUYING CRITERIA FOR CLINICAL MICROBIOLOGY PRODUCTS 89
TABLE 22 KEY COMPANIES IMPLEMENTING AI 93
TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES 95
TABLE 24 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 99
TABLE 25 CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY REGION,
2023–2030 (USD MILLION) 100
TABLE 26 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 27 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 28 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 29 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 30 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 31 CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 102
TABLE 32 CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 103
TABLE 33 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 34 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 35 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 36 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 37 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 38 CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 106
TABLE 39 CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY REGION,
2023–2030 (USD MILLION) 107
TABLE 40 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS,
BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 41 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 42 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 43 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS,
BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 44 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS,
BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 45 CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY REGION,
2023–2030 (USD MILLION) 110
TABLE 46 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS,
BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 47 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 48 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS,
BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 49 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS,
BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 50 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 51 CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS,
BY REGION, 2023–2030 (USD MILLION) 113
TABLE 52 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 53 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 54 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 55 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 56 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 57 CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS,
BY REGION, 2023–2030 (USD MILLION) 116
TABLE 58 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 59 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS,
BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 60 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS,
BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 61 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 62 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 63 CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY REGION, 2023–2030 (USD MILLION) 119
TABLE 64 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 65 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS,
BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 66 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 67 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 68 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL
AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 69 CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS,
BY REGION, 2023–2030 (USD MILLION) 122
TABLE 70 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 71 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 72 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 73 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 74 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 75 CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY REGION,
2023–2030 (USD MILLION) 125
TABLE 76 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS,
BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 77 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS,
BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 78 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS,
BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 79 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS,
BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 80 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 81 CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 82 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 83 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS,
BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 84 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 85 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 86 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 87 CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS,
BY REGION, 2023–2030 (USD MILLION) 131
TABLE 88 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 89 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 90 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 91 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 92 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 93 CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS,
BY REGION, 2023–2030 (USD MILLION) 134
TABLE 94 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 95 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 96 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 97 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 98 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 99 LIST OF COMMERCIALLY AVAILABLE MICROBIOLOGY ANALYZERS, 2023–2025 137
TABLE 100 CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY REGION, 2023–2030 (USD MILLION) 137
TABLE 101 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 102 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 103 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 104 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 105 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 106 CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 140
TABLE 107 CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 140
TABLE 108 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 109 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 110 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 111 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 112 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 113 CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY REGION,
2023–2030 (USD MILLION) 143
TABLE 114 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES,
BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 115 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 116 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES,
BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 117 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES,
BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 118 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 119 CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY REGION, 2023–2030 (USD MILLION) 146
TABLE 120 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 121 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS,
BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 122 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS,
BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 123 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 124 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 125 CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY REGION,
2023–2030 (USD MILLION) 149
TABLE 126 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 127 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY,
2023–2030 (USD MILLION) 150
TABLE 128 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 129 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 130 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 131 CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 151
TABLE 132 CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS,
BY REGION, 2023–2030 (USD MILLION) 152
TABLE 133 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 134 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS,
BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 135 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 136 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 137 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 138 CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY REGION,
2023–2030 (USD MILLION) 155
TABLE 139 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 140 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 141 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 142 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 157
TABLE 143 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 157
TABLE 144 CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY REGION,
2023–2030 (USD MILLION) 158
TABLE 145 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA,
BY COUNTRY, 2023–2030 (USD MILLION) 158
TABLE 146 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 147 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA,
BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 148 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA,
BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 149 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 150 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 162
TABLE 151 GLOBAL NUMBER OF NEWLY DIAGNOSED TUBERCULOSIS (TB) CASES,
2023–2030 (IN MILLION) 164
TABLE 152 CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2023–2030 (USD MILLION) 164
TABLE 153 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 164
TABLE 154 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 155 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 156 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 157 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 158 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS,
BY REGION, 2023–2030 (USD MILLION) 167
TABLE 159 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 160 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 168
TABLE 161 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 168
TABLE 162 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 169
TABLE 163 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 169
TABLE 164 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES,
BY REGION, 2023–2030 (USD MILLION) 170
TABLE 165 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 170
TABLE 166 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 171
TABLE 167 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 171
TABLE 168 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 172
TABLE 169 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 172
TABLE 170 CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES,
BY REGION, 2023–2030 (USD MILLION) 174
TABLE 171 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 172 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 173 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 174 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 175 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 176 CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2023–2030 (USD MILLION) 177
TABLE 177 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 177
TABLE 178 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 179 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 180 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 179
TABLE 181 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 179
TABLE 182 CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2023–2030 (USD MILLION) 180
TABLE 183 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 180
TABLE 184 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 181
TABLE 185 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 181
TABLE 186 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 187 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 188 CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION,
2023–2030 (USD MILLION) 183
TABLE 189 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 183
TABLE 190 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 184
TABLE 191 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 184
TABLE 192 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 193 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 194 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 187
TABLE 195 CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS,
BY REGION, 2023–2030 (USD MILLION) 188
TABLE 196 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 189
TABLE 197 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 189
TABLE 198 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 190
TABLE 199 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 190
TABLE 200 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 190
TABLE 201 CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES,
BY REGION, 2023–2030 (USD MILLION) 191
TABLE 202 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 192
TABLE 203 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 192
TABLE 204 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 193
TABLE 205 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 193
TABLE 206 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 193
TABLE 207 CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2023–2030 (USD MILLION) 194
TABLE 208 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 194
TABLE 209 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 195
TABLE 210 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 195
TABLE 211 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 196
TABLE 212 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 196
TABLE 213 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION) 198
TABLE 214 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 200
TABLE 215 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 201
TABLE 216 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 217 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 218 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 219 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 203
TABLE 220 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 203
TABLE 221 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 204
TABLE 222 NORTH AMERICA: MACROECONOMIC INDICATORS 204
TABLE 223 US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 206
TABLE 224 US: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 206
TABLE 225 US: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 226 US: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 227 US: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 208
TABLE 228 US: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 208
TABLE 229 US: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 209
TABLE 230 CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 210
TABLE 231 CANADA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 232 CANADA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 233 CANADA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 234 CANADA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 212
TABLE 235 CANADA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 212
TABLE 236 CANADA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 213
TABLE 237 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 214
TABLE 238 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 214
TABLE 239 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 240 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 215
TABLE 241 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 215
TABLE 242 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 216
TABLE 243 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 216
TABLE 244 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 217
TABLE 245 EUROPE: MACROECONOMIC INDICATORS 217
TABLE 246 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 218
TABLE 247 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 248 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 249 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 250 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 220
TABLE 251 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 221
TABLE 252 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 221
TABLE 253 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 222
TABLE 254 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 255 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 223
TABLE 256 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 224
TABLE 257 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 224
TABLE 258 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 225
TABLE 259 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 225
TABLE 260 UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 227
TABLE 261 UK: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 227
TABLE 262 UK: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 263 UK: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 264 UK: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 229
TABLE 265 UK: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 229
TABLE 266 UK: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 230
TABLE 267 ITALY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 231
TABLE 268 ITALY: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 231
TABLE 269 ITALY: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 270 ITALY: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 271 ITALY: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 233
TABLE 272 ITALY: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 233
TABLE 273 ITALY: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 234
TABLE 274 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 235
TABLE 275 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 276 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 236
TABLE 277 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 236
TABLE 278 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 237
TABLE 279 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 237
TABLE 280 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 238
TABLE 281 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 238
TABLE 282 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 283 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 284 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 285 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 286 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 241
TABLE 287 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 241
TABLE 288 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 243
TABLE 289 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 243
TABLE 290 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 291 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 292 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 293 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 245
TABLE 294 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 245
TABLE 295 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 246
TABLE 296 ASIA PACIFIC: MACROECONOMIC INDICATORS 246
TABLE 297 CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 247
TABLE 298 CHINA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 299 CHINA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 300 CHINA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 301 CHINA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 249
TABLE 302 CHINA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 250
TABLE 303 CHINA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 250
TABLE 304 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 252
TABLE 305 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 306 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 307 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 308 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 254
TABLE 309 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 254
TABLE 310 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 255
TABLE 311 INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 256
TABLE 312 INDIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 256
TABLE 313 INDIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 314 INDIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 315 INDIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 258
TABLE 316 INDIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 258
TABLE 317 INDIA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 259
TABLE 318 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 260
TABLE 319 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 320 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 321 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 322 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 323 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 262
TABLE 324 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 263
TABLE 325 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 264
TABLE 326 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 327 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 328 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 329 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 266
TABLE 330 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 266
TABLE 331 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 267
TABLE 332 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 268
TABLE 333 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 334 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 335 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 336 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS,
BY TYPE, 2023–2030 (USD MILLION) 270
TABLE 337 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 270
TABLE 338 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 271
TABLE 339 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 272
TABLE 340 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 272
TABLE 341 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 342 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 343 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 344 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS,
BY TYPE, 2023–2030 (USD MILLION) 274
TABLE 345 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 274
TABLE 346 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 275
TABLE 347 LATIN AMERICA: MACROECONOMIC INDICATORS 275
TABLE 348 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 276
TABLE 349 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 277
TABLE 350 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 277
TABLE 351 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 352 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 278
TABLE 353 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 279
TABLE 354 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 279
TABLE 355 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 280
TABLE 356 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE,
2023–2030 (USD MILLION) 280
TABLE 357 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,
BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 358 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 359 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE,
2023–2030 (USD MILLION) 282
TABLE 360 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2023–2030 (USD MILLION) 282
TABLE 361 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 283
TABLE 362 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 284
TABLE 363 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 284
TABLE 364 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 365 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 366 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS,
BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 367 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 286
TABLE 368 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 287
TABLE 369 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 288
TABLE 370 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 288
TABLE 371 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 289
TABLE 372 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 289
TABLE 373 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 290
TABLE 374 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS,
BY TYPE, 2023–2030 (USD MILLION) 290
TABLE 375 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 291
TABLE 376 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2023–2030 (USD MILLION) 291
TABLE 377 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 292
TABLE 378 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 293
TABLE 379 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 380 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR
LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 381 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 382 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR
REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 295
TABLE 383 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 295
TABLE 384 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET,
BY END USER, 2023–2030 (USD MILLION) 296
TABLE 385 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 297
TABLE 386 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 297
TABLE 387 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 298
TABLE 388 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 298
TABLE 389 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS,
BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 390 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 299
TABLE 391 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 300
TABLE 392 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 300
TABLE 393 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET
FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 301
TABLE 394 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET
FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 301
TABLE 395 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET
FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 302
TABLE 396 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET
FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 302
TABLE 397 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET,
BY DISEASE AREA, 2023–2030 (USD MILLION) 303
TABLE 398 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET,
BY END USER, 2023–2030 (USD MILLION) 303
TABLE 399 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET, JANUARY 2021−AUGUST 2025 304
TABLE 400 CLINICAL MICROBIOLOGY MARKET: INTENSITY OF COMPETITIVE RIVALRY 308
TABLE 401 CLINICAL MICROBIOLOGY MARKET: REGION FOOTPRINT 312
TABLE 402 CLINICAL MICROBIOLOGY MARKET: PRODUCT FOOTPRINT 313
TABLE 403 CLINICAL MICROBIOLOGY MARKET: INSTRUMENTS FOOTPRINT 314
TABLE 404 CLINICAL MICROBIOLOGY MARKET: DISEASE AREA FOOTPRINT 314
TABLE 405 CLINICAL MICROBIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 317
TABLE 406 CLINICAL MICROBIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2) 317
TABLE 407 CLINICAL MICROBIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2) 318
TABLE 408 CLINICAL MICROBIOLOGY MARKET: PRODUCT/SERVICE LAUNCHES &
APPROVALS, JANUARY 2021–AUGUST 2025 320
TABLE 409 CLINICAL MICROBIOLOGY MARKET: DEALS, JANUARY 2021–AUGUST 2025 321
TABLE 410 CLINICAL MICROBIOLOGY MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2025 322
TABLE 411 BIOMÉRIEUX: COMPANY OVERVIEW 323
TABLE 412 BIOMÉRIEUX: PRODUCTS/SERVICES OFFERED 325
TABLE 413 BIOMÉRIEUX: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2021–AUGUST 2025 327
TABLE 414 BIOMÉRIEUX: DEALS, JANUARY 2021–AUGUST 2025 328
TABLE 415 DANAHER CORPORATION: COMPANY OVERVIEW 331
TABLE 416 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 333
TABLE 417 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2021–AUGUST 2025 334
TABLE 418 DANAHER CORPORATION: DEALS, JANUARY 2021–AUGUST 2025 335
TABLE 419 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021−AUGUST 2025 335
TABLE 420 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 337
TABLE 421 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED 338
TABLE 422 BECTON, DICKINSON AND COMPANY: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025 340
TABLE 423 BECKTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–AUGUST 2025 341
TABLE 424 BECKTON, DICKINSON AND COMPANY: EXPANSIONS,
JANUARY 2021– AUGUST 2025 342
TABLE 425 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 343
TABLE 426 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 344
TABLE 427 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025 347
TABLE 428 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2025 348
TABLE 429 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 349
TABLE 430 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 350
TABLE 431 F. HOFFMANN-LA ROCHE LTD.: PRODUCT/SERVICE LAUNCHES AND
APPROVALS, JANUARY 2021–AUGUST 2025 351
TABLE 432 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–AUGUST 2025 352
TABLE 433 F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2021–AUGUST 2025 352
TABLE 434 ABBOTT LABORATORIES: COMPANY OVERVIEW 354
TABLE 435 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 356
TABLE 436 ABBOTT LABORATORIES: DEALS, JANUARY 2021−AUGUST 2025 361
TABLE 438 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 363
TABLE 439 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–AUGUST 2025 364
TABLE 440 BRUKER CORPORATION: COMPANY OVERVIEW 365
TABLE 441 BRUKER CORPORATION: PRODUCTS/SERVICES OFFERED 366
TABLE 442 BRUKER CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2021– AUGUST 2025 367
TABLE 443 BRUKER CORPORATION: DEALS, JANUARY 2021– AUGUST 2025 367
TABLE 444 HOLOGIC, INC.: COMPANY OVERVIEW 368
TABLE 445 HOLOGIC, INC.: PRODUCTS/SERVICES OFFERED 369
TABLE 446 HOLOGIC, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2021–AUGUST 2025 370
TABLE 447 HOLOGIC, INC.: DEALS, JANUARY 2021– AUGUST 2025 371
TABLE 448 MERCK KGAA: COMPANY OVERVIEW 372
TABLE 449 MERCK KGAA: PRODUCTS/SERVICES OFFERED 373
TABLE 450 MERCK KGAA: DEALS, JANUARY 2021–AUGUST 2025 374
TABLE 451 MERCK KGAA: EXPANSIONS, JANUARY 2021–AUGUST 2025 374
TABLE 452 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 376
TABLE 453 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 377
TABLE 454 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–AUGUST 2025 379
TABLE 455 QIAGEN: COMPANY OVERVIEW 380
TABLE 456 QIAGEN: PRODUCTS/SERVICES OFFERED 381
TABLE 457 QIAGEN: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–AUGUST 2025 382
TABLE 458 QIAGEN: DEALS, JANUARY 2021–AUGUST 2025 383
TABLE 459 QIAGEN: EXPANSIONS, JANUARY 2021–AUGUST 2025 383
TABLE 460 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 384
TABLE 461 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED 385
TABLE 462 SIEMENS HEALTHINEERS AG: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2025 386
TABLE 463 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021– AUGUST 2025 386
TABLE 464 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021– AUGUST 2025 387
TABLE 465 SHIMADZU CORPORATION: COMPANY OVERVIEW 388
TABLE 466 NEOGEN CORPORATION: COMPANY OVERVIEW 389
TABLE 467 SEEGENE INC.: COMPANY OVERVIEW 390
TABLE 468 RAPID MICRO BIOSYSTEMS, INC.: COMPANY OVERVIEW 391
TABLE 469 HARDY DIAGNOSTICS: COMPANY OVERVIEW 392
TABLE 470 EMSL ANALYTICAL, INC.: COMPANY OVERVIEW 395
TABLE 471 LIOFILCHEM S.R.L.: COMPANY OVERVIEW 396
TABLE 472 TCS BIOSCIENCES LTD.: COMPANY OVERVIEW 397
TABLE 473 MEMMERT GMBH + CO.KG: COMPANY OVERVIEW 398
TABLE 474 VACUTEST KIMA S.R.L: COMPANY OVERVIEW 399
TABLE 475 CREATIVE DIAGNOSTICS: COMPANY OVERVIEW 400
TABLE 476 DCN DX: COMPANY OVERVIEW 401
LIST OF FIGURES
FIGURE 1 CLINICAL MICROBIOLOGY MARKET SEGMENTATION & REGIONAL SCOPE 36
FIGURE 2 CLINICAL MICROBIOLOGY MARKET: RESEARCH DESIGN METHODOLOGY 40
FIGURE 3 PRIMARY SOURCES 43
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY & DEMAND-SIDE PARTICIPANTS 45
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 46
FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 47
FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 48
FIGURE 8 CLINICAL MICROBIOLOGY MARKET: TOP-DOWN APPROACH 49
FIGURE 9 DATA TRIANGULATION METHODOLOGY 50
FIGURE 10 CLINICAL MICROBIOLOGY MARKET: RESEARCH ASSUMPTIONS 51
FIGURE 11 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 53
FIGURE 12 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2025 VS.
2030 (USD MILLION) 54
FIGURE 13 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 55
FIGURE 14 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2025 VS. 2030 (USD MILLION) 55
FIGURE 15 HIGH PREVALENCE OF INFECTIOUS DISEASES AND TECHNOLOGICAL ADVANCEMENTS IN NOVEL DIAGNOSTICS TO DRIVE MARKET 57
FIGURE 16 INSTRUMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 58
FIGURE 17 RESPIRATORY DISEASES SEGMENT TO DOMINATE MARKET
DURING FORECAST PERIOD 58
FIGURE 18 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT TO DOMINATE
MARKET DURING FORECAST PERIOD 59
FIGURE 19 ASIA PACIFIC REGION TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 59
FIGURE 20 CLINICAL MICROBIOLOGY MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 60
FIGURE 21 PATENT ANALYSIS FOR CLINICAL MICROBIOLOGY
(JANUARY 2015–DECEMBER 2024) 68
FIGURE 22 VALUE CHAIN ANALYSIS OF CLINICAL MICROBIOLOGY MARKET: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES 70
FIGURE 23 CLINICAL MICROBIOLOGY MARKET: SUPPLY CHAIN ANALYSIS 72
FIGURE 24 CLINICAL MICROBIOLOGY MARKET: ECOSYSTEM ANALYSIS 74
FIGURE 25 CLINICAL MICROBIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 76
FIGURE 26 CLINICAL MICROBIOLOGY MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 87
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CLINICAL MICROBIOLOGY PRODUCTS 88
FIGURE 28 KEY BUYING CRITERIA FOR CLINICAL MICROBIOLOGY PRODUCTS 89
FIGURE 29 NUMBER OF DEALS & FUNDING ACTIVITIES IN CLINICAL
MICROBIOLOGY MARKET (2021−2024) 90
FIGURE 30 MARKET POTENTIAL OF AI IN CLINICAL MICROBIOLOGY MARKET 92
FIGURE 31 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 200
FIGURE 32 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 242
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN CLINICAL
MICROBIOLOGY MARKET (2022–2024) 307
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CLINICAL
MICROBIOLOGY MARKET (2024) 308
FIGURE 35 CLINICAL MICROBIOLOGY MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 311
FIGURE 36 CLINICAL MICROBIOLOGY MARKET: COMPANY FOOTPRINT 312
FIGURE 37 CLINICAL MICROBIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 316
FIGURE 38 EV/EBITDA OF KEY VENDORS 318
FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 319
FIGURE 40 CLINICAL MICROBIOLOGY MARKET: BRAND COMPARISON FOR INSTRUMENTS 319
FIGURE 41 BIOMÉRIEUX: COMPANY SNAPSHOT (2024) 324
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 332
FIGURE 43 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024) 338
FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 344
FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024) 350
FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 355
FIGURE 47 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 363
FIGURE 48 BRUKER CORPORATION: COMPANY SNAPSHOT (2024) 366
FIGURE 49 HOLOGIC, INC.: COMPANY SNAPSHOT (2024) 369
FIGURE 50 MERCK KGAA: COMPANY SNAPSHOT (2024) 373
FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 377
FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2024) 381
FIGURE 53 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 385
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11